Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR | Nature
BRAF Mutations in Colorectal Cancer: Clinical Relevance and Role in Targeted Therapy in: Journal of the National Comprehensive Cancer Network Volume 10 Issue 11 (2012)
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer | NEJM
Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY
Exploring the best treatment options for BRAF-mutant metastatic colon cancer | British Journal of Cancer
BRAF-Mutated Advanced Colorectal Cancer: A Rapidly Changing Therapeutic Landscape | Journal of Clinical Oncology
Art of using maintenance therapy in a patient with metastatic colon cancer harboring RAS-wt/BRAF V600E | Biomedical Research and Therapy
Cancers | Free Full-Text | The Evolutionary Landscape of Treatment for BRAFV600E Mutant Metastatic Colorectal Cancer
Colorectal IHC portfolio
Prise en charge du patient avec cancer colo-rectal métastatique (CCRm) BRAF muté – FMC-HGE
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
BRAF Biomarker | Colorectal Cancer Alliance
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Frontiers | BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer
The Evolving Treatment Landscape in BRAF-V600E–Mutated Metastatic Colorectal Cancer | American Society of Clinical Oncology Educational Book
BRAF Biomarker | Colorectal Cancer Alliance
SFPQ Depletion Is Synthetically Lethal with BRAFV600E in Colorectal Cancer Cells - ScienceDirect
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer - Xu - 2023 - Cancer Medicine - Wiley Online Library
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
